|
US4107288A
(en)
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
|
US5240938A
(en)
|
1991-02-13 |
1993-08-31 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
|
|
GB9020931D0
(en)
|
1990-09-26 |
1990-11-07 |
Wellcome Found |
Heterocyclic compounds
|
|
IE914572A1
(en)
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
|
IE914573A1
(en)
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
DK40192D0
(da)
*
|
1992-03-26 |
1992-03-26 |
Neurosearch As |
Imidazolforbindelser, deres fremstilling og anvendelse
|
|
US5468757A
(en)
|
1994-01-31 |
1995-11-21 |
Eli Lilly And Company |
6-azaindole thromboxane synthase inhibitors
|
|
AU2583901A
(en)
|
1999-12-17 |
2001-06-25 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
WO2003000187A2
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
|
JP2005089334A
(ja)
|
2003-09-12 |
2005-04-07 |
Sumitomo Pharmaceut Co Ltd |
８−ヒドロキシアデニン化合物
|
|
US20090264384A1
(en)
|
2004-11-01 |
2009-10-22 |
Nuada, Inc. |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
DE102004060699A1
(de)
|
2004-12-16 |
2006-06-22 |
Ratiopharm Gmbh |
Verfahren zur Herstellung von Candesartan
|
|
DE602005007384D1
(de)
|
2004-12-22 |
2008-07-17 |
Algry Quimica S L |
Zwischenprodukte für die herstellung von antagonisten des angiotensin-ii-rezeptors
|
|
ITMI20050801A1
(it)
|
2005-05-03 |
2006-11-04 |
Dipharma Spa |
Procedimento per la preparazione di telmisartan
|
|
WO2006125592A2
(en)
*
|
2005-05-24 |
2006-11-30 |
Lek Pharmaceuticals D.D. |
Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives
|
|
JP5321061B2
(ja)
|
2005-08-11 |
2013-10-23 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
不飽和複素環誘導体
|
|
CN100427488C
(zh)
|
2005-10-21 |
2008-10-22 |
上海东升新材料有限公司 |
腺嘌呤类衍生物及其合成方法
|
|
WO2007081755A2
(en)
|
2006-01-09 |
2007-07-19 |
Metabasis Therapeutics, Inc. |
Indole-benzimidazole and indazole inhibitors of tyrosine phosphatases
|
|
US20080008682A1
(en)
|
2006-07-07 |
2008-01-10 |
Chong Lee S |
Modulators of toll-like receptor 7
|
|
JP2009242240A
(ja)
|
2006-08-04 |
2009-10-22 |
Mebiopharm Co Ltd |
含ホウ素キナゾリン誘導体
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
TWI406850B
(zh)
|
2007-06-05 |
2013-09-01 |
Theravance Inc |
雙效苯并咪唑抗高血壓劑
|
|
JP2011506459A
(ja)
|
2007-12-11 |
2011-03-03 |
セラヴァンス， インコーポレーテッド |
抗高血圧剤としての二重作用性ベンゾイミダゾール誘導体およびその使用
|
|
KR20150065941A
(ko)
*
|
2008-03-06 |
2015-06-15 |
아나코르 파마슈티칼스 인코포레이티드 |
소염제로써 붕소가 함유된 소분자
|
|
EP2565191B1
(en)
|
2008-05-14 |
2014-10-08 |
Astellas Pharma Inc. |
4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
|
|
WO2010009029A2
(en)
|
2008-07-15 |
2010-01-21 |
Wyeth |
Methods for the preparation of azole compounds
|
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
WO2011053247A1
(en)
|
2009-10-29 |
2011-05-05 |
Agency For Science, Technology And Research |
Method for the detection of an analyte by surface enhanced raman spectroscopy (sers)
|
|
CN102971313A
(zh)
|
2010-04-14 |
2013-03-13 |
百时美施贵宝公司 |
新颖的葡糖激酶激活剂及其使用方法
|
|
EP3540059A1
(en)
*
|
2010-04-16 |
2019-09-18 |
Nuevolution A/S |
Bi-functional complexes and methods for making and using such complexes
|
|
AU2012212323A1
(en)
|
2011-02-01 |
2013-09-12 |
The Board Of Trustees Of The University Of Illinois |
HDAC inhibitors and therapeutic methods using the same
|
|
CN103502249A
(zh)
*
|
2011-05-17 |
2014-01-08 |
普林斯匹亚生物制药公司 |
作为酪氨酸激酶抑制剂的氮杂吲哚衍生物
|
|
JP6349256B2
(ja)
|
2011-11-09 |
2018-06-27 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染の治療のためのプリン誘導体
|
|
WO2013132253A1
(en)
|
2012-03-07 |
2013-09-12 |
Institute Of Cancer Research: Royal Cancer Hospital (The) |
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
|
|
PL3137470T3
(pl)
|
2014-05-01 |
2021-10-11 |
Novartis Ag |
Związki i kompozycje jako agonisty receptora toll-like 7
|
|
WO2016036887A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Fluorescence assay for intestinal permeability
|
|
WO2016055582A1
(en)
*
|
2014-10-08 |
2016-04-14 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
Heterocyclic compounds as dctpp1 modulators
|
|
WO2016200840A1
(en)
|
2015-06-08 |
2016-12-15 |
Cleave Biosciences, Inc. |
Mono and bicyclic ring boronic acid, ester and salt compounds as inhibitors of p97 complex
|
|
UA121775C2
(uk)
*
|
2015-07-31 |
2020-07-27 |
Пфайзер Інк. |
1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl
|
|
ES2984389T3
(es)
|
2016-06-29 |
2024-10-29 |
Univ Montreal |
Heterociclos de biarilmetilo
|
|
EP3558319A4
(en)
*
|
2016-12-22 |
2020-07-22 |
AbbVie Inc. |
COMPOSITIONS AND PROCESSES FOR IMPROVING OR INCREASING THE PRODUCTION OF TYPE I IFN
|
|
EA201991556A1
(ru)
|
2016-12-22 |
2020-01-23 |
Мавуфарма, Инк. |
Ингибиторы фосфодиэстеразы и способы лечения микробной инфекции
|
|
US10487084B2
(en)
*
|
2017-08-16 |
2019-11-26 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
|
|
TW201920104A
(zh)
|
2017-08-31 |
2019-06-01 |
美商馬愈法瑪公司 |
外核苷酸焦磷酸酶-磷酸二酯酶1(enpp-1)抑制劑及其用途
|
|
KR20240151869A
(ko)
|
2017-09-08 |
2024-10-18 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Enpp1 저해제 및 암의 치료용의 이의 용도
|
|
CN109206446B
(zh)
*
|
2017-11-14 |
2021-08-03 |
深圳市塔吉瑞生物医药有限公司 |
一种取代的含硼的化合物及包含该化合物的药物组合物
|
|
CN108409767B
(zh)
|
2018-04-13 |
2020-07-10 |
上海泰坦科技股份有限公司 |
一种杂环联苯硼酸的制备方法
|
|
WO2020140001A1
(en)
|
2018-12-28 |
2020-07-02 |
Riboscience Llc |
Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
|
|
JP7777332B2
(ja)
|
2019-02-01 |
2025-11-28 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
免疫応答をモジュレートするｅｎｐｐ１阻害剤および方法
|
|
WO2020191501A1
(en)
|
2019-03-27 |
2020-10-01 |
Algernon Pharmaceuticals Inc. |
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
|
WO2021053507A1
(en)
|
2019-09-16 |
2021-03-25 |
Aten Porus Lifesciences Pvt. Ltd. |
2-amino-s6-substituted thiopurine compounds as inhibitors of the enpp1 protein
|
|
KR20220068243A
(ko)
|
2019-09-23 |
2022-05-25 |
난징 젱시앙 파마슈티칼스 컴퍼니 리미티드 |
포스포디에스테라제 억제제 및 용도
|
|
US20230121698A1
(en)
|
2019-12-23 |
2023-04-20 |
Sanford Burnham Prebys Medical Discovery Institute |
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) modulators and uses thereof
|
|
KR20220138399A
(ko)
|
2020-02-04 |
2022-10-12 |
스팅레이 테라퓨릭스, 인크. |
엑토뉴클레오티드 피로포스파타제/포스포디에스테라제 1(enpp1)의 억제제 및 이의 사용 방법
|
|
WO2021203772A1
(en)
|
2020-04-09 |
2021-10-14 |
Betta Pharmaceuticals Co., Ltd |
Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors,compositions and uses thereof
|